The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: Identification and characterization of the primary demyelinating lesion

Brain

Volumn 120, Issue 8, 1997, Pages

  Gay, F W ^a   Drye, T J ^a   Dick, G W A ^a   Esiri, M M ^b  

^a ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Cluster analysis; Primary multiple sclerosis plaque

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN; MYELIN;

ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLUSTER ANALYSIS; DEMYELINATION; DISEASE COURSE; DISEASE DURATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; PLAQUE FORMING CELL; PRIORITY JOURNAL; REMYELINIZATION; T LYMPHOCYTE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLUSTER ANALYSIS; DEMYELINATING DISEASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; PLASMA CELLS;

EID: 1842367972     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.8.1461     Document Type: Article

References (49)

1. Adams CWM. Pathology of multiple sclerosis: progression of the lesion. [Review]. Br Med Bull 1977; 33: 15-20.
2. Adams CWM. Vascular aspects of multiple sclerosis. In: Adams CWM. A colour atlas of multiple sclerosis and other myelin disorders. London: Wolfe Medical, 1989: 184-7.
3. Adams CWM, Poston RN, Buk SJ. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 1989; 92: 291-306.
4. Banfield JD, Raftery AE. Model based Gaussian and non-Gaussian clustering. Biometrics 1993; 49: 803-22.
5. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. [Review]. Neurology 1995; 45 (6 Suppl 6): S16-21.
6. Compston DAS, Morgan BP, Campbell AK, Wilkins P, Cole G, Thomas ND, et al. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 1989;15: 307-16.
7. Coyle P. Analysis of immune complexes in multiple sclerosis. In: Lowenthal A, Raus J, editors. Cellular and humoral immunological components of cerebrospinal fluid in multiple sclerosis. New York: Plenum Press, 1987: 129-37.
8. Davey FR, Cordell JL, Erber WN, Pulford KAF, Gatter KC, Mason DY. Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages. J Clin Pathol 1988; 41: 753-8.
9. Dawson JW. The histology of disseminated sclerosis. Trans Roy Soc Edin 1916; 50: 517-740.
10. Esiri MM. Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet 1977; 2: 478.
11. Esiri MM. Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. Neuropathol Appl Neurobiol 1980; 6: 9-21.
12. Esiri MM, Gay D. Immunological and neuropathological significance of the Virchow-Robin space. [Review]. J Neurol Sci 1990;100: 3-8.
13. Esiri MM, Gay D. The immunocytochemistry of multiple sclerosis plaques. In: Raine CS, McFarland HF, Tourtellotte WW, editors. Multiple sclerosis. Clinical and pathogenetic basis. London: Chapman and Hall, 1997: 173-85.
14. Esiri MM, Reading MC. Macrophage populations associated with multiple sclerosis plaques. Neuropathol Appl Neurobiol 1987; 13: 451-65.
15. Esiri MM, Oppenheimer DR, Brownell B, Haire M. Distribution of measles antigen and immunoglobulin-containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis. J Neurol Sci 1982; 53: 29-43.
16. Esiri MM, Reading MC, Squier MV, Hughes JT. Immunocytochemical characterization of the macrophage and lymphocyte infiltrate in the brain in six cases of human encephalitis of varied aetiology. Neuropathol Appl Neurobiol 1989; 15: 289-305.
17. Everitt BS. Cluster analysis. 3rd ed. London: Edward Arnold,1993.
18. Fabry Z, Raine CS, Hart MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. [Review]. Immunol Today 1994; 15: 218-24.
19. Fowlkes EB, Mallows CL. A method for comparing two hierarchical clusterings. J Am Stat Assoc 1983; 78: 553-69.
20. Franklin WA, Mason DY, Pulford K, Falini B, Bliss E, Gatter KC, et al. Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest 1986; 54: 322-35.
21. Gay D, Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study. Brain 1991; 114: 557-72.
22. Groome N, Harland J, Dawkes A. Preparation and properties of monoclonal antibodies to myelin basic protein and its peptides. Neurochem Int 1985; 7: 309-17.
23. Hafler DA, Weiner HL. MS: a CNS and systemic autoimmune disease. [Review]. Immunol Today 1989; 10: 104-7.
24. Hays AP, Lee SSL, Latov N. Immune reactive C3d on the surface of myelin sheaths in neuropathy. J Neuroimmunol 1988; 18: 231-44.
25. Janossy G, Bofill M, Poulter LW, Rawlings E, Burford GD, Navarrete C, et al. Separate ontogeny of two macrophage-like accessory cell populations in the human fetus. J Immunol 1986; 136: 4354-61.
26. Li H, Newcombe J, Groome NP, Cuzner ML. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol 1993; 19: 214-23.
27. Linington C, Lassmann H, Morgan BP, Compston DAS. Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis. Acta Neuropathol (Berl) 1989; 79: 78-85.
28. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. [Review]. Brain Pathol 1996; 6: 259-74.
29. McCallum K, Esiri MM, Tourtellotte WW, Booss J. T cell subsets in multiple sclerosis. Gradients at plaque borders and differences in nonplaque regions. Brain 1987; 110: 1297-308.
30. Newcombe J, Cuzner ML. Monoclonal antibody 14E identifies the oligodendrocyte cell body in normal adult human and rat white matter. J Neuroimmunol 1988; 19: 11-20.
31. Pambakian S, Poston RN. The binding of immunoglobulin Fc to cationic proteins. Clin Exp Immunol 1987; 68: 402-8.
32. Pelfrey CM, Tranquill LR, Vogt AB, McFarland HF. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls. Multiple Sclerosis 1996; 1: 270-8.
33. Prineas JW. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 1979; 203: 1123-5.
34. Prineas JW. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology, Vol. 47. Amsterdam: Elsevier, 1985: 213-57.
35. Prineas JW, Graham JS. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 1980; 10: 149-58.
36. Raine CS. Multiple sclerosis: immune system molecule expression in the central nervous system. [Review]. J Neuropathol Exp Neurol 1994; 53: 328-37.
37. Rand WM. Objective criteria for the evaluation of clustering methods. J Amer Stat Assoc 1971; 66: 846-50.
38. Ransohoff RM, Tuohy V, Lehmann P. The immunology of multiple sclerosis: new intricacies and new insights. [Review]. Curr Opin Neurol 1994; 7: 242-9.
39. Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res 1985; 326: 47-63
40. Sanders V, Conrad AJ, Tourtellotte WW. On classification of post-mortem multiple sclerosis plaques for neuroscientists. J Neuroimmunol 1993; 46: 207-16.
41. Sekijima Y, Tokuda T, Hashimoto T, Koh C-S, Shoji S, Yanagisawa N. Serial magnetic resonance imaging (MRI) study of a patient with Bale's concentric sclerosis treated with immunoadsorption plasmapheresis. Multiple Sclerosis 1997; 2: 291-4.
42. Sharief MK, Thompson EJ. Intrathecal immunoglobulin M synthesis in multiple sclerosis. Brain 1991; 114: 181-95.
43. Tavolato BF. Immunoglobulin G distribution in multiple sclerosis brain. An immunofluorescence study. J Neurol Sci 1975; 24: 1-11.
44. Tsukada T, McNutt MA, Ross R, Gown AM. HHF35, a muscle actin-specific monoclonal antibody: II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol 1987; 127: 389-402.
45. Utz U, McFarland HF. The role of T cells in multiple sclerosis: implications for therapies targeting the T cell receptor. [Review]. J Neuropathol Exp Neurol 1994; 53: 351-8.
46. Venables WN, Ripley BD. Modern applied statistics with S-PLUS. New York: Springer-Verlag, 1994.
47. Walker RWH, Keir G, Johnson MH, Thompson EJ. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol 1983; 4: 141-8.
48. Woodroofe MN. Cytokine production in the central nervous system. [Review]. Neurology 1995; 45(6 Suppl 6): S6-10.
49. Zhang ET, Richards HK, Kida S, Weller RO. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol (Berl) 1992; 83: 233-9.